Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals, Inc. (REGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 872589.
Total stock buying since 2005: $2,475,753,844.
Total stock sales since 2005: $14,586,084,237.
Total stock option exercises since 2005: $1,313,104,322.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 210,364 | $207,522,474 | 616,322 | $254,112,622 |
| 2023 | 0 | $0 | 95,808 | $78,349,729 | 273,334 | $75,352,970 |
| 2022 | 0 | $0 | 209,705 | $142,182,035 | 469,330 | $145,352,340 |
| 2021 | 0 | $0 | 563,365 | $351,623,746 | 2,003,096 | $333,732,044 |
| 2020 | 0 | $0 | 24,311,062 | $12,445,396,750 | 1,955,372 | $164,839,706 |
| 2019 | 0 | $0 | 416,206 | $143,310,975 | 917,671 | $23,311,139 |
| 2018 | 0 | $0 | 427,003 | $148,810,340 | 927,576 | $18,552,974 |
| 2017 | 462,141 | $212,021,764 | 137,384 | $65,407,790 | 900,886 | $27,301,249 |
| 2016 | 148,669 | $62,482,433 | 20,663 | $8,394,544 | 774,368 | $17,691,794 |
| 2015 | 260,466 | $131,463,987 | 420,930 | $219,457,542 | 678,280 | $37,168,578 |
| 2014 | 6,498,829 | $2,040,580,495 | 592,551 | $211,494,397 | 1,689,378 | $74,072,416 |
| 2013 | 0 | $0 | 979,452 | $254,768,275 | 1,464,593 | $33,265,521 |
| 2012 | 0 | $0 | 1,215,019 | $159,380,088 | 2,319,093 | $46,475,631 |
| 2011 | 0 | $0 | 729,476 | $37,856,945 | 1,678,597 | $36,895,258 |
| 2010 | 1,034,901 | $28,971,078 | 317,918 | $9,118,977 | 332,278 | $5,014,862 |
| 2009 | 12,500 | $234,087 | 114,271 | $2,249,950 | 651,002 | $5,760,483 |
| 2008 | 0 | $0 | 156,479 | $3,272,738 | 500,195 | $4,022,051 |
| 2007 | 0 | $0 | 224,867 | $5,157,435 | 316,441 | $3,033,949 |
| 2006 | 0 | $0 | 443,650 | $8,648,660 | 580,125 | $5,427,485 |
| 2005 | 0 | $0 | 7,562,667 | $83,680,847 | 135,000 | $1,721,250 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-16 | Murphy Andrew J (EVP Research) | Sale | 7,167 | 651.16 | 4,666,885 |
| 2021-11-16 | Landry Robert E (EVP Finance CFO) | Option Ex | 3,750 | 399.66 | 1,498,725 |
| 2021-11-16 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Sale | 6,778 | 656.32 | 4,448,557 |
| 2021-11-16 | Sing George L (Director) | Sale | 6,750 | 654.70 | 4,419,211 |
| 2021-11-15 | Murphy Andrew J (EVP Research) | Option Ex | 16,579 | 52.03 | 862,605 |
| 2021-11-15 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Option Ex | 25,000 | 270.43 | 6,760,750 |
| 2021-11-01 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 640.00 | 640,000 |
| 2021-11-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2021-11-01 | Ryan Arthur F (Director) | Sale | 100 | 642.92 | 64,292 |
| 2021-10-01 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 576.75 | 576,750 |
| 2021-10-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2021-10-01 | Ryan Arthur F (Director) | Sale | 100 | 569.44 | 56,944 |
| 2021-09-15 | Coles N Anthony (Director) | Sale | 11,948 | 658.26 | 7,864,866 |
| 2021-09-15 | Coles N Anthony (Director) | Option Ex | 11,948 | 363.21 | 4,339,633 |
| 2021-09-13 | Tessier-lavigne Marc (Director) | Sale | 12,750 | 644.43 | 8,216,546 |
| 2021-09-13 | Tessier-lavigne Marc (Director) | Option Ex | 12,750 | 273.67 | 3,489,292 |
| 2021-09-13 | Brown Michael S (Director) | Sale | 9,704 | 644.47 | 6,253,927 |
| 2021-09-13 | Brown Michael S (Director) | Option Ex | 9,704 | 402.54 | 3,906,219 |
| 2021-09-10 | Goldstein Joseph L (Director) | Sale | 2,479 | 650.00 | 1,611,350 |
| 2021-09-10 | Goldstein Joseph L (Director) | Option Ex | 2,479 | 380.95 | 944,375 |
| 2021-09-01 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 674.72 | 674,720 |
| 2021-09-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2021-09-01 | Ryan Arthur F (Director) | Sale | 100 | 678.55 | 67,855 |
| 2021-08-31 | Landry Robert E (EVP Finance CFO) | Option Ex | 1,000 | 555.67 | 555,670 |
| 2021-08-30 | Sing George L (Director) | Sale | 1,550 | 671.75 | 1,041,212 |
| 2021-08-27 | Poon Christine A (Director) | Sale | 15,000 | 667.47 | 10,011,975 |
| 2021-08-27 | Poon Christine A (Director) | Option Ex | 15,000 | 57.11 | 856,650 |
| 2021-08-26 | Sing George L (Director) | Sale | 150 | 672.00 | 100,800 |
| 2021-08-25 | Vagelos P Roy (Director) | Option Ex | 75,000 | 179.13 | 13,434,750 |
| 2021-08-23 | Fenimore Christopher R. (SVP Controller) | Sale | 4,781 | 661.08 | 3,160,642 |
| 2021-08-23 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 3,425 | 664.47 | 2,275,820 |
| 2021-08-20 | Fenimore Christopher R. (SVP Controller) | Option Ex | 13,500 | 179.13 | 2,418,255 |
| 2021-08-20 | Larosa Joseph J (EVP General Counsel and Secret) | Option Ex | 10,000 | 179.13 | 1,791,300 |
| 2021-08-19 | Schleifer Leonard S (President & CEO) | Sale | 10,000 | 660.03 | 6,600,300 |
| 2021-08-18 | Schleifer Leonard S (President & CEO) | Sale | 200,000 | 650.03 | 130,006,000 |
| 2021-08-18 | Coles N Anthony (Director) | Sale | 5,100 | 650.00 | 3,315,000 |
| 2021-08-18 | Coles N Anthony (Director) | Option Ex | 5,100 | 345.47 | 1,761,897 |
| 2021-08-18 | Vagelos P Roy (Director) | Sale | 10,039 | 650.04 | 6,525,751 |
| 2021-08-17 | Coles N Anthony (Director) | Sale | 900 | 650.00 | 585,000 |
| 2021-08-17 | Coles N Anthony (Director) | Option Ex | 900 | 345.47 | 310,923 |
| 2021-08-16 | Bassler Bonnie L (Director) | Sale | 1,219 | 630.00 | 767,970 |
| 2021-08-16 | Bassler Bonnie L (Director) | Option Ex | 1,219 | 376.69 | 459,185 |
| 2021-08-16 | Yancopoulos George (President and Chief Scientific) | Sale | 49,227 | 625.67 | 30,800,103 |
| 2021-08-16 | Sing George L (Director) | Sale | 1,705 | 628.75 | 1,072,018 |
| 2021-08-16 | Schleifer Leonard S (President & CEO) | Sale | 10,000 | 622.54 | 6,225,410 |
| 2021-08-13 | Yancopoulos George (President and Chief Scientific) | Sale | 773 | 625.00 | 483,125 |
| 2021-08-13 | Sing George L (Director) | Sale | 500 | 620.00 | 310,000 |
| 2021-08-13 | Coles N Anthony (Director) | Sale | 2,000 | 625.00 | 1,250,000 |
| 2021-08-13 | Coles N Anthony (Director) | Option Ex | 2,000 | 345.47 | 690,940 |
| 2021-08-12 | Sing George L (Director) | Sale | 1,000 | 611.00 | 611,000 |
| 2021-08-11 | Sing George L (Director) | Sale | 2,300 | 620.33 | 1,426,765 |
| 2021-08-10 | Landry Robert E (EVP Finance CFO) | Sale | 537 | 615.20 | 330,363 |
| 2021-08-10 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Sale | 6,603 | 611.40 | 4,037,107 |
| 2021-08-10 | Sing George L (Director) | Sale | 2,600 | 614.00 | 1,596,407 |
| 2021-08-09 | Landry Robert E (EVP Finance CFO) | Sale | 364 | 616.84 | 224,530 |
| 2021-08-09 | Landry Robert E (EVP Finance CFO) | Option Ex | 3,000 | 381.92 | 1,145,760 |
| 2021-08-09 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Option Ex | 25,000 | 270.43 | 6,760,750 |
| 2021-08-09 | Brown Michael S (Director) | Sale | 1,687 | 612.38 | 1,033,085 |
| 2021-08-06 | Landry Robert E (EVP Finance CFO) | Option Ex | 2,000 | 381.92 | 763,840 |
| 2021-08-06 | Sing George L (Director) | Sale | 4,350 | 611.69 | 2,660,864 |
| 2021-08-06 | Schleifer Leonard S (President & CEO) | Option Ex | 400,000 | 52.03 | 20,812,000 |
| 2021-08-05 | Bassler Bonnie L (Director) | Sale | 2,559 | 600.00 | 1,535,400 |
| 2021-08-05 | Bassler Bonnie L (Director) | Option Ex | 2,559 | 391.92 | 1,002,923 |
| 2021-08-05 | Yancopoulos George (President and Chief Scientific) | Sale | 50,000 | 600.06 | 30,002,999 |
| 2021-08-02 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 577.12 | 577,120 |
| 2021-08-02 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2021-08-02 | Ryan Arthur F (Director) | Sale | 100 | 576.48 | 57,648 |
| 2021-07-06 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 3,398 | 580.00 | 1,970,840 |
| 2021-07-02 | Larosa Joseph J (EVP General Counsel and Secret) | Option Ex | 10,000 | 179.13 | 1,791,300 |
| 2021-06-25 | Brown Michael S (Director) | Sale | 2,084 | 549.00 | 1,144,116 |
| 2021-06-25 | Brown Michael S (Director) | Option Ex | 2,084 | 371.40 | 773,997 |
| 2021-06-21 | Yancopoulos George (President and Chief Scientific) | Sale | 80,000 | 538.04 | 43,043,040 |
| 2021-06-07 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 511.65 | 511,650 |
| 2021-06-07 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2021-06-07 | Goldstein Joseph L (Director) | Sale | 1,930 | 525.00 | 1,013,250 |
| 2021-06-07 | Goldstein Joseph L (Director) | Option Ex | 1,930 | 374.12 | 722,051 |
| 2021-05-07 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 495.63 | 495,630 |
| 2021-05-07 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2021-02-23 | Vagelos P Roy (Director) | Option Ex | 250,000 | 52.03 | 13,007,500 |
| 2021-02-01 | Ryan Arthur F (Director) | Sale | 100 | 507.82 | 50,781 |
| 2021-01-25 | Brown Michael S (Director) | Sale | 2,480 | 554.32 | 1,374,713 |
| 2021-01-25 | Brown Michael S (Director) | Option Ex | 2,480 | 380.95 | 944,756 |
| 2021-01-04 | Ryan Arthur F (Director) | Sale | 100 | 484.54 | 48,454 |
| 2020-12-30 | Yancopoulos George (President and Chief Scientific) | Option Ex | 398,079 | 52.03 | 20,712,050 |
| 2020-12-01 | Ryan Arthur F (Director) | Sale | 100 | 520.00 | 51,999 |
| 2020-11-17 | Murphy Andrew J (EVP Research) | Sale | 6,628 | 545.61 | 3,616,309 |
| 2020-11-16 | Murphy Andrew J (EVP Research) | Option Ex | 13,736 | 30.63 | 420,733 |
| 2020-11-13 | Coles N Anthony (Director) | Option Ex | 11 | 345.47 | 3,800 |
| 2020-11-02 | Ryan Arthur F (Director) | Sale | 100 | 548.92 | 54,891 |
| 2020-10-22 | Murphy Andrew J (EVP Research) | Option Ex | 5,185 | 41.33 | 214,296 |
| 2020-10-05 | Mccourt Marion (SVP Commercial) | Sale | 1,000 | 600.00 | 600,000 |
| 2020-10-05 | Mccourt Marion (SVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2020-10-05 | Goldstein Joseph L (Director) | Sale | 9,212 | 600.00 | 5,527,200 |
| 2020-10-05 | Goldstein Joseph L (Director) | Option Ex | 9,212 | 520.01 | 4,790,332 |
| 2020-10-01 | Ryan Arthur F (Director) | Sale | 100 | 559.51 | 55,951 |
| 2020-09-22 | Goldstein Joseph L (Director) | Sale | 20 | 552.36 | 11,047 |
| 2020-09-22 | Brown Michael S (Director) | Sale | 6,090 | 552.36 | 3,363,872 |
| 2020-09-22 | Brown Michael S (Director) | Option Ex | 5,090 | 378.82 | 1,928,193 |
| 2020-09-21 | Goldstein Joseph L (Director) | Sale | 16,554 | 549.63 | 9,098,608 |
| 2020-09-21 | Goldstein Joseph L (Director) | Option Ex | 16,574 | 376.35 | 6,237,575 |
| 2020-09-01 | Ryan Arthur F (Director) | Sale | 100 | 603.76 | 60,375 |
| 2020-08-31 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 4,672 | 615.04 | 2,873,466 |
| 2020-08-31 | Sing George L (Director) | Sale | 10,000 | 612.43 | 6,124,299 |
| 2020-08-28 | Poon Christine A (Director) | Sale | 40,000 | 601.02 | 24,040,920 |
| 2020-08-28 | Poon Christine A (Director) | Option Ex | 40,000 | 29.43 | 1,177,400 |
| 2020-08-27 | Larosa Joseph J (EVP General Counsel and Secret) | Option Ex | 10,000 | 52.03 | 520,300 |
| 2020-08-25 | Van Plew Daniel P (EVP & General Mgr Industrial O) | Sale | 27,109 | 611.98 | 16,590,111 |
| 2020-08-25 | Sing George L (Director) | Sale | 33,750 | 607.74 | 20,511,326 |
| 2020-08-25 | Sing George L (Director) | Option Ex | 12,750 | 273.67 | 3,489,292 |
| 2020-08-24 | Sing George L (Director) | Sale | 20,037 | 594.91 | 11,920,231 |
| 2020-08-24 | Sing George L (Director) | Option Ex | 10,037 | 177.82 | 1,784,779 |
| 2020-08-21 | Goldstein Joseph L (Director) | Sale | 1,000 | 617.18 | 617,180 |
| 2020-08-21 | Sing George L (Director) | Sale | 19,963 | 606.58 | 12,109,056 |
| 2020-08-21 | Sing George L (Director) | Option Ex | 9,963 | 117.47 | 1,170,303 |
| 2020-08-20 | Mccourt Marion (SVP Commercial) | Sale | 1,000 | 612.15 | 612,150 |
| 2020-08-20 | Mccourt Marion (SVP Commercial) | Option Ex | 1,000 | 342.93 | 342,930 |
| 2020-08-20 | Van Plew Daniel P (EVP & General Mgr Industrial O) | Option Ex | 75,000 | 179.13 | 13,434,750 |
| 2020-08-20 | Sing George L (Director) | Sale | 21,000 | 617.45 | 12,966,450 |
| 2020-08-20 | Sing George L (Director) | Option Ex | 10,000 | 57.11 | 571,100 |
| 2020-08-11 | Vagelos P Roy (Director) | Sale | 33,460 | 601.32 | 20,120,100 |
| 2020-08-04 | Landry Robert E (EVP Finance CFO) | Sale | 696 | 654.46 | 455,504 |
| 2020-08-03 | Ryan Arthur F (Director) | Sale | 100 | 640.50 | 64,049 |
| 2020-07-21 | Fenimore Christopher R. (VP Controller) | Sale | 3,709 | 643.32 | 2,386,077 |
| 2020-07-21 | Landry Robert E (EVP Finance CFO) | Sale | 391 | 652.75 | 255,225 |
| 2020-07-20 | Fenimore Christopher R. (VP Controller) | Option Ex | 12,224 | 115.58 | 1,412,849 |
| 2020-07-20 | Landry Robert E (EVP Finance CFO) | Option Ex | 8,500 | 477.67 | 4,060,152 |
| 2020-07-14 | Murphy Andrew J (EVP Research) | Sale | 6,309 | 628.13 | 3,952,586 |
| 2020-07-14 | Landry Robert E (EVP Finance CFO) | Sale | 579 | 640.50 | 370,849 |
| 2020-07-13 | Murphy Andrew J (EVP Research) | Sale | 8,000 | 627.10 | 5,016,768 |
| 2020-07-13 | Murphy Andrew J (EVP Research) | Option Ex | 13,000 | 30.63 | 398,190 |
| 2020-07-09 | Landry Robert E (EVP Finance CFO) | Option Ex | 3,000 | 399.66 | 1,198,980 |
| 2020-07-08 | Landry Robert E (EVP Finance CFO) | Sale | 1,160 | 642.09 | 744,827 |
| 2020-07-07 | Zoghbi Huda Y (Director) | Sale | 1,706 | 650.00 | 1,108,900 |
| 2020-07-07 | Zoghbi Huda Y (Director) | Option Ex | 1,706 | 391.92 | 668,615 |
| 2020-07-07 | Landry Robert E (EVP Finance CFO) | Option Ex | 12,500 | 477.67 | 5,970,812 |
| 2020-07-07 | Sing George L (Director) | Sale | 10,500 | 650.28 | 6,827,961 |
| 2020-07-07 | Sing George L (Director) | Option Ex | 7,500 | 33.42 | 250,650 |
| 2020-07-01 | Ryan Arthur F (Director) | Sale | 100 | 612.44 | 61,244 |
| 2020-07-01 | Brown Michael S (Director) | Sale | 3,613 | 611.03 | 2,207,665 |
| 2020-07-01 | Brown Michael S (Director) | Option Ex | 3,613 | 413.33 | 1,493,361 |
| 2020-06-29 | Landry Robert E (EVP Finance CFO) | Sale | 400 | 612.60 | 245,040 |
| 2020-06-29 | Sing George L (Director) | Sale | 3,000 | 608.51 | 1,825,524 |
| 2020-06-23 | Landry Robert E (EVP Finance CFO) | Sale | 512 | 630.67 | 322,903 |
| 2020-06-22 | Landry Robert E (EVP Finance CFO) | Option Ex | 8,900 | 555.67 | 4,945,463 |
| 2020-06-19 | Bassler Bonnie L (Director) | Sale | 2,559 | 630.69 | 1,613,935 |
| 2020-06-19 | Bassler Bonnie L (Director) | Option Ex | 2,559 | 391.92 | 1,002,923 |
| 2020-06-16 | Fenimore Christopher R. (VP Controller) | Sale | 3,556 | 588.96 | 2,094,338 |
| 2020-06-15 | Fenimore Christopher R. (VP Controller) | Option Ex | 9,406 | 41.33 | 388,749 |
| 2020-06-11 | Zoghbi Huda Y (Director) | Sale | 1,706 | 625.00 | 1,066,250 |
| 2020-06-11 | Zoghbi Huda Y (Director) | Option Ex | 1,706 | 391.92 | 668,615 |
Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals, Inc. (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.